Aspira Pathlab & Diagnostics informs about disclosure

16 Mar 2024 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed disclosure, Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from MJay Arvind Bhanushali, Promoters Immediate Relative of the Company for the acquisition of Equity Shares from the market as on March 14, 2024 and March 15, 2024 respectively.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

55.03 2.03 (3.83%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.